ASCO Immunotherapy Roundup - 4: Merck KGaA Trailing Rivals with ADCC-Inducing Avelumab

Koichi Katsura, Head of R&D Japan, Merck Serono Merck KGaA’s tie-up with Pfizer on the investigational anti-PD-L1 antibody avelumab made headlines last year. In the fourth of this series, we sat down with the Japan R&D head of Merck Serono,...read more